BioCryst Pharmaceuticals BCRX Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from BioCryst Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's quick ratio?
- BioCryst Pharmaceuticals (BCRX) reported quick ratio of 1.8× in Q1 2026.
- How has BioCryst Pharmaceuticals's quick ratio changed year-over-year?
- BioCryst Pharmaceuticals's quick ratio decreased by 35.8% year-over-year, from 2.8× to 1.8×.
- What is the long-term trend for BioCryst Pharmaceuticals's quick ratio?
- Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's quick ratio has grown at a -8.3% compound annual growth rate (CAGR), from 3× to 1.9×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.